TipRanks
55% OFF
PC:MOSAN

Mosanna Therapeutics

Mosanna Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for obstructive sleep apnea. The company is advancing a novel nasal spray designed to provide an effective and user-friendly alternative to traditional sleep apnea therapies. By leveraging cutting-edge research and technology, Mosanna Therapeutics aims to address the growing need for accessible and efficient sleep disorder solutions.

Leadership & Board

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$80M
Total Funding Rounds
1
Latest Funding Amount
$80M
Latest Funding Round
Series A
Post-Money Valuation
―

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 25, 2025Series A$80.00M―

Investors

Investor NameFunding Round
ForbionSeries A
Pivotal bioVenture PartnersSeries A
EQT Life SciencesSeries A
Broadview VenturesSeries A
NorwestSeries A

Similar Companies

A snapshot of private companies similar to Mosanna Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis